Krystal Biotech, Inc. technical analysis
Technical analysis of Krystal Biotech, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Krystal Biotech, Inc.
Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK for the treatment of dystrophic epidermolysis bullosa and develops multiple therapeutic candidates in various clinical stages for ophthalmological, dermatological, and other disease conditions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Krystal Biotech, Inc.: latest session data
Closing values for October 16, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
332.47 $
−4.78%
50 sessions
339.77 $
−6.83%
200 sessions
305.46 $
+3.64%
Session levels
s2
322.07
Support
s1
326.04
Support
pivot
332.47
Pivot
r1
336.44
Resistance
r2
342.87
Resistance
How to read it
In the October 16, 2026 session Krystal Biotech, Inc. closed lower at 316.58 $, −4.07% versus the previous session.
The price sits mixed against its moving averages: −4.78% against the 21-session average, −6.83% against the 50 and +3.64% against the 200.
The 14-period RSI reads 39.1, in neutral territory.
MACD stands at -4.984 against a signal line at -4.429: the histogram is negative (−0.555).
ADX reads 11.7, indicating weak directionality.
Levels computed on the latest session place supports at 326.04 and 322.07 $ and resistances at 336.44 and 342.87 $, around a pivot of 332.47.
The average daily range (ATR) is 11.283 $, or 3.56% of price.
Turnover was 226.1K shares, 85% of the 20-session average.
Over the last twelve months the price ranged between 251.97 and 382.54 $, and today stands −17.24% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the KRYS analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Krystal Biotech, Inc.
How is Krystal Biotech, Inc. analysed technically?
Technical analysis of Krystal Biotech, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Krystal Biotech, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Krystal Biotech, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Krystal Biotech, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.